Similar articles

• Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.

  Hubschwerlen C, Specklin JL, Sigwalt C, Schroeder S, Locher HH. Hubschwerlen C, et al. Bioorg Med Chem. 2003 May 15;11(10):2313-9. doi: 10.1016/s0968-0896(03)00083-x. Bioorg Med Chem. 2003. PMID: 12713843
• Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

  Mitscher LA. Mitscher LA. Chem Rev. 2005 Feb;105(2):559-92. doi: 10.1021/cr030101q. Chem Rev. 2005. PMID: 15700957 Review. No abstract available.
• Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.

  Panda SS, Liaqat S, Girgis AS, Samir A, Hall CD, Katritzky AR. Panda SS, et al. Bioorg Med Chem Lett. 2015 Sep 15;25(18):3816-21. doi: 10.1016/j.bmcl.2015.07.077. Epub 2015 Jul 26. Bioorg Med Chem Lett. 2015. PMID: 26253630
• Rational choice of an oral beta-lactam antibiotic.

  Periti P. Periti P. J Chemother. 1997 Sep;9 Suppl 4:1-23. J Chemother. 1997. PMID: 9373786 Review. No abstract available.
• Clinical impact of in vitro data with newer quinolones.

  Smith JT. Smith JT. J Chemother. 1989 Jul;1(4 Suppl):662-3. J Chemother. 1989. PMID: 16312581 No abstract available.